The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat

被引:100
作者
Wan, FJ
Swerdlow, NR
机构
[1] UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT PSYCHIAT,LA JOLLA,CA 92093
关键词
limbic cortex; prepulse inhibition; startle; schizophrenia;
D O I
10.1016/S0306-4522(96)00218-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The acoustic startle reflex is a coordinated contraction of the skeletal musculature in response to a sudden, intense sound. One form of startle plasticity, ''prepulse inhibition'', is the normal suppression of the startle reflex when the intense startling stimulus is immediately preceded by a weak pre-stimulus. Prepulse inhibition is utilized as an operational measure of sensorimotor gating, and is significantly impaired in several neuropsychiatric disorders that are characterized by symptoms associated with central inhibitory deficits. In rats, prepulse inhibition is disrupted by central dopamine activation or by manipulations of limbic cortical structures including the prefrontal cortex and hippocampus. In the present study, we assessed prepulse inhibition in rats after surgical and pharmacologic manipulations of the basolateral amygdala. Quinolinic acid lesions of the basolateral amygdala significantly reduced prepulse inhibition without significantly changing startle amplitude. These lesions also blocked fear-potentiated startle, which is known to be regulated by the basolateral amygdala. The prepulse inhibition-disruptive effects of basolateral amygdala lesions were not reversed by systemic injection of the dopamine antagonist haloperidol at doses that totally restored prepulse inhibition in apomorphine-treated rats. In other studies, intra-amygdala infusion of the competitive N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovaleric acid (0, 0.15, 1.5, 4.5 mu g) dose-dependently reduced prepulse inhibition. These data suggest that the basolateral amygdala regulates sensorimotor gating by mechanisms that are independent of central dopamine hyperactivity. Copyright (C) 1996 IBRO.
引用
收藏
页码:715 / 724
页数:10
相关论文
共 50 条
[31]  
SANANES CB, 1992, BEHAV NEUROSCI, V105, P817
[32]   PREFRONTAL CORTICAL EFFERENTS IN THE RAT SYNAPSE ON UNLABELED NEURONAL TARGETS OF CATECHOLAMINE TERMINALS IN THE NUCLEUS-ACCUMBENS-SEPTI AND ON DOPAMINE NEURONS IN THE VENTRAL TEGMENTAL AREA [J].
SESACK, SR ;
PICKEL, VM .
JOURNAL OF COMPARATIVE NEUROLOGY, 1992, 320 (02) :145-160
[33]   IN THE RAT MEDIAL NUCLEUS-ACCUMBENS, HIPPOCAMPAL AND CATECHOLAMINERGIC TERMINALS CONVERGE ON SPINY NEURONS AND ARE IN APPOSITION TO EACH OTHER [J].
SESACK, SR ;
PICKEL, VM .
BRAIN RESEARCH, 1990, 527 (02) :266-279
[34]   GABAERGIC PROJECTION FROM NUCLEUS-ACCUMBENS TO VENTRAL PALLIDUM MEDIATES DOPAMINE-INDUCED SENSORIMOTOR GATING DEFICITS OF ACOUSTIC STARTLE IN RATS [J].
SWERDLOW, NR ;
BRAFF, DL ;
GEYER, MA .
BRAIN RESEARCH, 1990, 532 (1-2) :146-150
[35]   IMPAIRED PREPULSE INHIBITION OF ACOUSTIC AND TACTILE STARTLE RESPONSE IN PATIENTS WITH HUNTINGTONS-DISEASE [J].
SWERDLOW, NR ;
PAULSEN, J ;
BRAFF, DL ;
BUTTERS, N ;
GEYER, MA ;
SWENSON, MR .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (02) :192-200
[36]  
SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139
[37]   A PRELIMINARY ASSESSMENT OF SENSORIMOTOR GATING IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER [J].
SWERDLOW, NR ;
BENBOW, CH ;
ZISOOK, S ;
GEYER, MA ;
BRAFF, DL .
BIOLOGICAL PSYCHIATRY, 1993, 33 (04) :298-301
[38]   SEROQUEL (ICI-204,636) RESTORES PREPULSE INHIBITION OF ACOUSTIC STARTLE IN APOMORPHINE-TREATED RATS - SIMILARITIES TO CLOZAPINE [J].
SWERDLOW, NR ;
ZISOOK, D ;
TAAID, N .
PSYCHOPHARMACOLOGY, 1994, 114 (04) :675-678
[39]   PREPULSE INHIBITION OF ACOUSTIC STARTLE IN RATS AFTER LESIONS OF THE PEDUNCULOPONTINE TEGMENTAL NUCLEUS [J].
SWERDLOW, NR ;
GEYER, MA .
BEHAVIORAL NEUROSCIENCE, 1993, 107 (01) :104-117
[40]   Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats [J].
Swerdlow, NR ;
Lipska, BK ;
Weinberger, DR ;
Braff, DL ;
Jaskiw, GE ;
Geyer, MA .
PSYCHOPHARMACOLOGY, 1995, 122 (01) :27-34